← Back to guidelines
Emergency Medicine67 papers

Zika virus disease

Last edited: 4/15/2026

Overview

Zika virus disease is an acute infectious condition caused by the Zika virus, primarily transmitted through Aedes mosquito bites, sexual contact, blood transfusions, and from mother to fetus 2. It often presents with mild symptoms but can lead to severe complications including Guillain-Barré Syndrome (GBS) and congenital ZIKV syndrome 2.

Diagnosis

  • Clinical Presentation: Body aches, joint pain, fatigue, malaise, fever, conjunctivitis, and maculopapular rash 2.
  • Laboratory Testing: Detection of Zika virus RNA in blood or other body fluids via RT-PCR; serological tests can be used but cross-reactivity with other flaviviruses is common 2.
  • Imaging: Not typically required for diagnosis but may be used to assess neurological complications 2.
  • Management

  • Supportive Care: Most patients are managed conservatively with rest, hydration, and symptomatic treatment 2.
  • GBS Management: Intravenous immunoglobulins have been used, similar to conventional GBS treatment 2.
  • No Specific Antiviral Therapy: Currently, no antiviral therapy is available for ZIKV infection 2.
  • Special Populations

  • Pregnancy: ZIKV infection during pregnancy can lead to congenital ZIKV syndrome; pregnant women should avoid areas with active transmission and use strict mosquito protection 2.
  • Neurological Complications: Special attention required for patients developing Guillain-Barré Syndrome or other neurological manifestations, with close monitoring and supportive care 2.
  • Key Recommendations

  • Implement Mosquito Control Measures: Use of mosquito repellents, protective clothing, and environmental management to prevent mosquito breeding 2. (Evidence: Expert opinion)
  • Screen and Manage Pregnant Women: Pregnant women in affected areas should be screened for ZIKV infection and provided with appropriate counseling and care 2. (Evidence: Expert opinion)
  • Supportive Care for Symptomatic Patients: Focus on supportive care including hydration and pain management for symptomatic individuals 2. (Evidence: Moderate)
  • References

    1 Norris SL, Louis H, Sawin VI, Porgo TV, Lau YHA, Wang Q et al.. An evaluation of WHO emergency guidelines for Zika virus disease. Journal of evidence-based medicine 2019. link 2 Silva GS, Richards GA, Baker T, Hidalgo J, Jiménez JIS, Amin P. Zika virus: Report from the task force on tropical diseases by the world Federation of Societies of intensive and critical care medicine. Journal of critical care 2018. link

    Original source

    1. [1]
      An evaluation of WHO emergency guidelines for Zika virus disease.Norris SL, Louis H, Sawin VI, Porgo TV, Lau YHA, Wang Q et al. Journal of evidence-based medicine (2019)
    2. [2]
      Zika virus: Report from the task force on tropical diseases by the world Federation of Societies of intensive and critical care medicine.Silva GS, Richards GA, Baker T, Hidalgo J, Jiménez JIS, Amin P Journal of critical care (2018)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG